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INTRODUCTION
The species Vibrio cholerae is Gram-negative bacilli and has
been classified according to the carbohydrate determinants
of its somatic O antigens (1). Approximately 200 serotypes
have been defined and are classified broadly into two type:
those agglutinate in antisera to the O1 group antigen (O1
V. cholerae) and those do not agglutinate in antisera to the
O1 group antigen (non-O1 V. cholerae) (2). Infections caused
by V. cholerae of serogroups other than O1 or O139 usually
manifest with sporadic diarrhea; however, in immunocom-
promised patients such as those with liver disease, renal fail-
ure, or hematologic malignancy, the infection can cause severe
extraintestinal diseases such as wound infection and sepsis
(3-6). Here we report, the first case of V. cholerae infection asso-
ciated with pleural effusion, with a focus on the unusual route
of infection and long-term latent V. cholerae carrier state.
CASE REPORT
The patient was a 62-yr-old man who had undergone cura-
tive subtotal gastrectomy for gastric cancer 14 yr ago. He pre-
sented himself with signs of cachexia and complained of heart-
burn and epigastric discomfort for approximately 1 month
before admission. The endoscopic examination revealed a
recurred gastric adenocarcinoma. A total gastrectomy and
Roux-en-Y esophagojejunostomy were performed with dis-
section of the multiple adhesions around the small sac and
between the transeverse colon and liver.
Four days after the operation, the patient developed fever.
He also showed consolidation in the left lower chest and
increasing pleural effusion on chest radiography. Thoracos-
tomy was performed. Because Klebsiella pneumoniae and Can-
dida albicans grew in the cultures of sputum and pleural effu-
sion, antibiotics treatment including intravenous cefepime
and clindamycin was initiated. Although the regimen was
changed to meropenem, the empyema on the left side did
not improve, and decortication of the left lung was performed
30 days after the operation. After decortication, no more mic-
roorganisms were isolated from pleural effusion. However,
methicilin-resistant coagulase-negative staphylococci was
recovered from the exudates of the tube insertion site. Despite
the vancomycin treatment, the wound did not improve, and
marginal resection of the tube insertion site was performed
15 days after decortication. After marginal resection, vanco-
mycin-resistant enterococci (VRE) was recovered in the cul-
ture of exudates from the wound site. The abdominal com-
puted tomography showed multiple abscesses in the left upper
abdomen at that time. Two days after the marginal resection,
the patient underwent re-exploration of the left thoracic cavity
due to a hemothorax from intercostal arterial bleeding at the resec-
tion site. The laboratory findings showed white blood cell
count of 19,100/ L with a neutrophil predominance (85%),
increased ESR (72 mm/hr) and CRP (28.34 mg/dL). In the
culture of blood and exudates from the pleural cavity obtained
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Vibrio cholerae non-O1, non-O139 Isolated from Pleural Effusion 
Following Total Gastrectomy
We isolated non-O1, non-O139 Vibrio cholerae from pleural effusion in a patient
with recurred advanced gastric caner after total gastrectomy. We also recovered
the organism from the patient’s stool culture. The patient did not experience gas-
trointestinal symptoms such as diarrhea except heartburn and epigastric discomfort
from stomach cancer before admission. The suspected route of infection is directly
from the gastrointestinal tract through the previous surgical wounds. After antibiotic
treatment, no more V. cholerae was isolated and the patient was well discharged
from the hospital. This is the first report of V. cholerae infection associated with pleu-
ral effusion in a long-term latent carrier of the organism.
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during exploration, both VRE and V. cholerae were recovered.
The patient was treated with linezolid, imipenem and levo-
floxacin. VRE and V. cholerae were also isolated in the patient’s
stool. No more pathogens were isolated on follow-up cultures
of pleural effusion, rectal swab and stool, and the laboratory
findings were normalized.
V. cholerae isolated from the pleural effusion and stool formed
white beta-hemolytic colonies on sheep blood agar and yellow
colonies on thiosulfate-citrate-bile sucrose agar. It was iden-
tified as V. cholerae by the MicroScan Gram-negative Combo
panel (Dade International Inc., Califonia, U.S.A.) and API
20E (bioMerieux, France). It was susceptible to amikacin,
ceftazidime, ceftriaxone, cephalothin, ciprofloxacin, gentam-
icin, imipenem, piperacillin, tobramycin, trimethoprim-sul-
famethoxazole and cefepime. The PCR for the cholera toxin
gene was performed with primers, 5′ -ACAGAGTGAGTA-
CTTTGACC-3′and 5′ -ATACCATCCATATATTTGGG-
AG-3′ , which did not yield a PCR product at 307 bp. By
agglutination test for serogrouping, the isolate was finally
confirmed as a non-cholera toxin-producing, non-O1, non-O139
V. cholerae.
DISCUSSION
The majority of infections by V. cholerae are associated with
the intake of contaminated food. However, V. cholerae includ-
ing O1 and O139, which requires salt for growth, is a nor-
mal flora of water, and enters into a dormant, viable but non-
culturable stage when conditions are unfavorable. The spo-
radic and erratic occurrence of cholera epidemics has been
associated with certain conditions that increase proliferation
of plankton, such as flood, El Nino (7). 
The stomach acidity is the main barrier against the infec-
tion of V. cholerae. The use of antacids, histamine receptor
blockers, and proton pump inhibitors increases the risk of
cholera and predisposes patients to a more severe disease beca-
use of reduced gastric acidity (8), and this is also the case in
patients with chronic gastritis secondary to Helicobacter pylori
infection and those who have undergone gastrectomy. Altho-
ugh there was a report of a carrier of V. cholerae in the gall-
bladder up to 12 yr (9), a long-term carrier of V. cholerae is
extremely rare, compared to those of Salmonella typhi.
The present patient did not develop gastrointestinal symp-
toms, except heartburn and epigastric discomfort due to sto-
mach cancer before admission. Therefore, it could be more
probable for the bacteria to have been resided in the gallblad-
der or intestinal tract rather than recent infection. It was sup-
ported by the fact that it took one month to yield V. cholerae
after total gastrectomy during the present admission. Consid-
ering the fact that rectal swab and stool cultures yielded the
same bacteria as well as VRE and that there was no apparent
history of intake of suspicious food, the patient was thought
to be a long-term carrier. The previous subtotal gastrectomy
and antacid drugs might have increased the susceptibility to
V. cholerae. Although we could not identify the route of infec-
tion associated with pleural effusion, it was presumed that
V. cholerae in multiple abscesses in the left upper abdomen was
translocated to the pleural cavity during the suctional treatment
for hemothorax.
Based on in vitro susceptibility tests, V. cholerae (non-O1)
strains are generally susceptible to most of antimicrobial agents
(10). Although the treatment of choice for V. cholerae is tetra-
cycline, the patient was successfully treated with linezolid,
imipenem and levofloxacin. The present case represents the
first case of V. cholerae infection associated with pleural effu-
sion in a long-term carrier of the organism. 
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